France Pharmaceuticals & Healthcare Views

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Bull Charges Into Telecare Sector

IT services provider Bull has secured two important new contracts within the French healthcare sector, leveraging the group's expansive cloud computing platforms. Bull is looking to double its EBIT...

Read article ›

Pages